Miyake Satoshi, Yanagisawa Yuka, Yuasa Yasuhito
Department of Molecular Oncology, Tokyo Medical and Dental University, Graduate School of Medicine and Dentistry, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
J Biol Chem. 2003 May 9;278(19):17060-5. doi: 10.1074/jbc.M212212200. Epub 2003 Feb 13.
An EID-1 (E1A-like inhibitor of differentiation-1) inhibits differentiation by blocking the histone acetyltransferase activity of p300. Here we report a novel inhibitor of differentiation exhibiting homology to EID-1, termed EID-2 (EID-1-like inhibitor of differentiation-2). EID-2 inhibited MyoD-dependent transcription and muscle differentiation. Unlike EID-1, EID-2 did not block p300 activity. Interestingly, EID-2 associated with class I histone deacetylases (HDACs). The N-terminal portion of EID-2 was required for the binding to HDACs. This region was also involved in the transcriptional repression and nuclear localization, suggesting the importance of the involvement of HDACs in the EID-2 function. These results indicate a new family of differentiation inhibitors, although there are several differences in the biochemical mechanisms between EID-2 and EID-1.
E1A样分化抑制因子1(EID-1)通过阻断p300的组蛋白乙酰转移酶活性来抑制分化。在此,我们报告了一种与EID-1具有同源性的新型分化抑制因子,称为EID-2(EID-1样分化抑制因子2)。EID-2抑制MyoD依赖的转录和肌肉分化。与EID-1不同,EID-2不阻断p300活性。有趣的是,EID-2与I类组蛋白去乙酰化酶(HDACs)相关联。EID-2的N端部分是与HDACs结合所必需的。该区域也参与转录抑制和核定位,表明HDACs参与EID-2功能的重要性。这些结果表明存在一个新的分化抑制因子家族,尽管EID-2和EID-1之间在生化机制上存在一些差异。